help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Pang, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Pang, S.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 291-295, Copyright © 1996 by Endocrine Society


ARTICLES

A new compound heterozygous frameshift mutation in the type II 3 beta- hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia

L Zhang, H Sakkal-Alkaddour, YT Chang, X Yang and S Pang
Department of Pediatrics, University of Illinois at Chicago, College of Medicine 60612, USA.

We report a new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in a Pakistanian female child with the salt-wasting form of 3 beta-HSD deficiency congenital adrenal hyperplasia. The child, born with clitoral enlargement, manifesting salt-wasting adrenal crisis, and public hair growth during infancy, was treated with hormonal replacement therapy. The etiology of her congenital adrenal hyperplasia, however, was not defined. Two of her siblings, as well as one paternal cousin with ambiguous genitalia and palpable gonads and another paternal cousin with normal female genitalia, had symptoms of adrenal crisis and died during early infancy. Thus, although the family history suggested possible 3 beta-HSD deficiency disorder, suppressed adrenal function caused by excess glucocorticoid therapy in this child at 7 yr of age did not allow hormonal diagnosis. To confirm 3 beta-HSD deficiency, we sequenced the type II 3 beta-HSD gene in the patient, her family, and the parents of her decreased paternal cousins. The type II 3 beta-HSD gene region of a putative promoter, exons I, II, III, and IV, and exon-intron boundaries were amplified by PCR and sequenced in all subjects. The DNA sequence of the child revealed a single nucleotide deletion at codon 318 [ACA (Thr)-->AA] in exon IV in one allele, and two nucleotide deletions at codon 273 [AAA(Lys)-->A] in exon IV in the other allele. The remaining gene sequences were normal. The codon 318 mutation was found in one allele from the father, brother, and parents of the deceased paternal cousins. The codon 273 mutation was found in one allele of the mother and a sister. These findings confirmed inherited 3 beta-HSD deficiency in the child caused by the compound heterozygous type II 3 beta-HSD gene mutation. Both codon 273 and 318 mutations yielding frameshift and premature stop codons at codons 279 and 367, respectively, are predicted to result in an altered and truncated type II 3 beta-HSD protein, thereby causing salt-wasting 3 beta-HSD deficiency in the patient. The type II 3 beta- HSD gene findings and clinical history of her family members suggest that the patient's deceased siblings were likely affected males with the same compound heterozygous mutations of the gene as in the proband, whereas the deceased cousins were likely affected with the homozygous codon 318 mutation in the gene.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner
Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family
Endocr. Rev., June 1, 2005; 26(4): 525 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Pang, W. Wang, B. Rich, R. David, Y. T. Chang, G. Carbunaru, S. E. Myers, A. F. Howie, K. J. Smillie, and J. I. Mason
A Novel Nonstop Mutation in the Stop Codon and a Novel Missense Mutation in the Type II 3{beta}-Hydroxysteroid Dehydrogenase (3{beta}-HSD) Gene Causing, Respectively, Nonclassic and Classic 3{beta}-HSD Deficiency Congenital Adrenal Hyperplasia
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2556 - 2563.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Lutfallah, W. Wang, J. I. Mason, Y. T. Chang, A. Haider, B. Rich, M. Castro-Magana, K. C. Copeland, R. David, and S. Pang
Newly Proposed Hormonal Criteria via Genotypic Proof for Type II 3{beta}-Hydroxysteroid Dehydrogenase Deficiency
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2611 - 2622.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Alos, A.-M. Moisan, L. Ward, M. Desrochers, L. Legault, G. Leboeuf, G. Van Vliet, and J. Simard
A Novel A10E Homozygous Mutation in the HSD3B2 Gene Causing Severe Salt-Wasting 3{beta}-Hydroxysteroid Dehydrogenase Deficiency in 46,XX and 46,XY French-Canadians: Evaluation of Gonadal Function after Puberty
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1968 - 1974.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Zhang, J. I. Mason, Y. Naiki, K. C. Copeland, M. Castro-Magana, T. T. Gordon-Walker, Y. T. Chang, and S. Pang
Characterization of Two Novel Homozygous Missense Mutations Involving Codon 6 and 259 of Type II 3{beta}-Hydroxysteroid Dehydrogenase (3{beta}HSD) Gene Causing, Respectively, Nonsalt-Wasting and Salt-Wasting 3{beta}HSD Deficiency Disorder
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1678 - 1685.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
New Insight into the Molecular Basis of 3{beta}-Hydroxysteroid Dehydrogenase Deficiency: Identification of Eight Mutations in the HSD3B2 Gene in Eleven Patients from Seven New Families and Comparison of the Functional Properties of Twenty-Five Mutant Enzymes
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4410 - 4425.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society